Biophagy’s anti-viral program with Dr. Bradfute (UNM) is being extended to include zika and hanta viruses By jordan|2022-02-01T19:12:15+00:00February 1, 2022|2022-announcements|0 Comments Read More
Biophagy is awarded a STEP grant through the NM Department of Economic Development for upgrading its website. This will help attract international partners and collaborators. By jordan|2022-03-22T20:32:58+00:00February 1, 2022|2021-announcements|0 Comments Read More
Biophagy initiates a collaboration with Dr. Ramesh Jha, Los Alamos National Laboratories, to study its antiviral compounds using molecular docking. This will help determine ligand affinity and specificity for use in lead development. By jordan|2022-03-22T20:33:09+00:00February 1, 2022|2021-announcements|0 Comments Read More
Biophagy announces the granting of a USPTO composition-of-matter patent for several compounds in its BPY-100 series. These proprietary molecules have shown activity in assays related to tuberculosis, covid-19, and neurodegenerative disorders. By jordan|2022-03-22T20:35:45+00:00February 1, 2022|2021-announcements|0 Comments Read More
Biophagy presents “Examining the Potency of Potential Autophagy Inducing Drugs,” at a UNM Discovery Symposium By jordan|2022-03-22T20:33:35+00:00February 1, 2022|2020-announcements|0 Comments Read More
Biophagy initiates a new program to study its proprietary compounds in SARS-CoV-2 (covid-19). These studies will be conducted by Dr. Steven Bradfute at UNM. By jordan|2022-03-22T20:33:48+00:00February 1, 2022|2020-announcements|0 Comments Read More
Biophagy announces the addition of Bhaskar Suda, PhD, to its team of consultants. Bhaskar will develop and run autophagy measuring assays and study proprietary compounds in neurodegenerative disorders. By jordan|2022-02-01T19:10:56+00:00February 1, 2022|2020-announcements|0 Comments Read More
Biophagy institutes a new division, CellWatch™, to develop its over-the-counter/direct-to-consumer products for the stimulation and measurement of autophagy in individuals. By jordan|2022-03-22T20:37:21+00:00February 1, 2022|2020-announcements|0 Comments Read More
Biophagy presents “Potential of Proprietary Molecules for Inducing Autophagy and Enhancing Antibiotic Treatment of Tuberculosis” at the Keystone Symposium, Tuberculosis: Immunity and Immune Evasion,” Santa Fe, NM By jordan|2022-02-01T19:10:32+00:00February 1, 2022|2020-announcements|0 Comments Read More
Biophagy presents “Autophagy: From Model Systems to Therapeutic Opportunities, 2/19/19, Keystone Symposium, Santa Fe, NM. By jordan|2022-02-01T19:10:18+00:00February 1, 2022|2019-announcements|0 Comments Read More
